Bispecific antibodies as novel bioconjugates

被引:55
作者
Cao, Y [1 ]
Suresh, MR [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
D O I
10.1021/bc980044l
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bispecific antibodies are unique macromolecular heterobifunctional cross-linkers with two different binding specificities within a single molecule. As ideal bioconjugates, they can specifically glue any two different molecules together without the need for chemical conjugation. With this unique feature, they have immense potential in biological and immunological fields. Their applications range from immunohistochemistry, immunoassays, ra, radioimmunotherapy, and immunotherapy. Recently, a new second generation of bispecific molecules, bispecific single chain Fv and diabodies, has been produced by DNA recombinant technology. They can be considered as the ultimate magic bullets for in vivo applications. They may theoretically improve tumor or pathogen targeting and minimize side effects, eventually replacing the full-length bispecific antibodies. Emphasizing on developmental methodology and clinical applications of bispecific antibodies, this review gives a bird's-eye view of these unique bioconjugates.
引用
收藏
页码:635 / 644
页数:10
相关论文
共 121 条
  • [1] MONOCLONAL-ANTIBODY TARGETING OF METHOTREXATE(MTX) AGAINST MTX-RESISTANT TUMOR-CELL LINES
    AFFLECK, K
    EMBLETON, MJ
    [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (06) : 838 - 844
  • [2] ANTIGEN-BINDING PROPERTIES OF HIGHLY PURIFIED BISPECIFIC ANTIBODIES
    ALLARD, WJ
    MORAN, CA
    NAGEL, E
    COLLINS, G
    LARGEN, MT
    [J]. MOLECULAR IMMUNOLOGY, 1992, 29 (10) : 1219 - 1227
  • [3] ANDERSON PM, 1992, BLOOD, V80, P2826
  • [4] DEVELOPMENT OF A BISPECIFIC MONOCLONAL-ANTIBODY FOR USE IN MOLECULAR HYBRIDIZATION
    AURIOL, J
    GUESDON, JL
    MAZIE, JC
    NATO, F
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 169 (01) : 123 - 133
  • [5] AZUMA A, 1992, CANCER RES, V52, P4890
  • [6] LYSIS OF TUMOR-CELLS BY THE RETARGETING OF MURINE CYTOLYTIC LYMPHOCYTES-T WITH BISPECIFIC ANTIBODIES
    BARR, IG
    MACDONALD, HR
    BUCHEGGER, F
    VONFLIEDNER, V
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) : 423 - 429
  • [7] BISPECIFIC ANTIBODIES THAT MEDIATE KILLING OF CELLS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS OF ANY STRAIN
    BERG, J
    LOTSCHER, E
    STEIMER, KS
    CAPON, DJ
    BAENZIGER, J
    JACK, HM
    WABL, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 4723 - 4727
  • [8] Berkova N, 1996, BIOTECHNOL APPL BIOC, V23, P163
  • [9] T-CELL TARGETING IN CANCER-THERAPY
    BOLHUIS, RLH
    STURM, E
    BRAAKMAN, E
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (01) : 1 - 8
  • [10] BOLHUIS RLH, 1992, INT J CANCER, P78